ReNeuron Group (RENE) News Today GBX 3.38 -0.08 (-2.17%) (As of 02/5/2024) Add Compare Share Share Headlines Stock AnalysisInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ReNeuron Group (LON:RENE) Stock Passes Below 200 Day Moving Average - What's Next?November 21 at 4:25 AM | americanbankingnews.comTRADING UPDATES: PetroTal buys Peru's Block 131 for USD5.0 millionMay 17, 2024 | lse.co.ukReNeuron CFO steps down to pursue other opportunitiesApril 17, 2024 | lse.co.ukMedtech firm IQ Endoscopes plans to create 100 new jobs and raise millionsApril 2, 2024 | msn.comUpland Resources shares soar as company prepares for Sarawak drillingMarch 28, 2024 | lse.co.ukCompany given millions of public money in Welsh Gov's disastrous foray into biotech investments collapses into administrationMarch 22, 2024 | msn.comTRADING UPDATES: ReNeuron appoints administrators as rescue talks failMarch 20, 2024 | lse.co.ukReNeuron Group PLC RENEFebruary 21, 2024 | morningstar.comTrident Royalties secures USD40 million revolving credit facilityFebruary 19, 2024 | lse.co.ukTRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash returnFebruary 5, 2024 | lse.co.ukReneuron issues administration warning as biotech firm puts jobs at riskFebruary 5, 2024 | msn.comReNeuron interim loss narrows on lower costs; eyes partnershipsNovember 8, 2023 | lse.co.ukReNeuron Group plc (LON:RENE): Is Breakeven Near?September 18, 2023 | finance.yahoo.comReNeuron Group Slides As Insider Purchases Lose Another UK£75kMay 19, 2023 | finance.yahoo.comReNeuron Group Slides As Insider Purchases Lose Another UK£75k \May 19, 2023 | finance.yahoo.com2023 Neuronal Cell Culture Media Market Size and Research Report in Medical Devices & Consumables Sector | with [104 Pages] and Forecast till 2031May 16, 2023 | marketwatch.comGlobal Retinitis Pigmentosa Treatment & Management Market Report 2023-2030: Top Growth Opportunities and TrendsMay 13, 2023 | marketwatch.comCritical Limb Ischemia Drug Market Size by 2031April 27, 2023 | marketwatch.comPlacental Stem Cell Therapy Market [2023-2030]: Detailed Growth AnalysisApril 20, 2023 | marketwatch.comStem Cell Therapy Market Size, Revenue, and Forecast 2030April 7, 2023 | marketwatch.comGlobal Market for Stem Cells 2023: Potential as Disease Treatment Options Fuels Market MomentumMarch 28, 2023 | uk.finance.yahoo.comGlobal Market for Stem CellsMarch 21, 2023 | uk.finance.yahoo.comReNeuron to present at Advanced Therapies 2023 conferenceMarch 13, 2023 | proactiveinvestors.comReNeuron Group’s investment potential ‘remains intact’, 2024 cash runway secured, says LiberumFebruary 13, 2023 | proactiveinvestors.comReNeuron Group Cuts 40% of Staff, Cash Extended into 2024January 19, 2023 | marketwatch.comRetinitis Pigmentosa (Retinitis) Market Massive Growth Strikes Due To Technological Innovation During 2023-2028January 5, 2023 | marketwatch.comReNeuron Group PLC: Chairman takes the reins as CEO steps downJanuary 3, 2023 | proactiveinvestors.comReNeuron CEO Catherine Isted Steps Down; Iain Ross Appointed ChairmanJanuary 3, 2023 | marketwatch.comReNeuron Group: chairman takes the reins as CEO steps downJanuary 3, 2023 | proactiveinvestors.comReNeuron Group (RENE): Pushing on with CustomEx in H123December 7, 2022 | finance.yahoo.comReNeuron Group First Half 2023 Earnings: UK£0.056 loss per share (vs UK£0.092 loss in 1H 2022)December 4, 2022 | finance.yahoo.comReNeuron Says New Data From CustomEx Platform Supports Monetization StrategyOctober 7, 2022 | marketwatch.comReNeuron Group data points to effectiveness of its ground-breaking technologyOctober 7, 2022 | proactiveinvestors.comReNeuron Appoints New CFOSeptember 15, 2022 | marketwatch.comReNeuron Group names John Hawkins as chief financial officer in boardroom reshuffleSeptember 14, 2022 | proactiveinvestors.comReNeuron Group plc (RENE.L)August 25, 2022 | uk.finance.yahoo.comSMALL CAP IDEA: ReNeuron finance boss says changes at biotech research firm mirror previous roleAugust 22, 2022 | msn.comReNeuron CEO: 'We have a great company that just needed a shake-up'August 22, 2022 | proactiveinvestors.comReNeuron Group Names CFO Catherine Isted as CEOAugust 2, 2022 | marketwatch.comEXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO roleAugust 1, 2022 | lse.co.ukReNeuron Group plc (RNUGF) Management on Q4 2022 Results - Earnings Call TranscriptJuly 5, 2022 | seekingalpha.comStem Cell Market Size Analysis Report 2022 by Manufacturing Base Distribution, Sales Area and Product Type by Player and Forecasts to 2029April 13, 2022 | marketwatch.comReNeuron Group PLC (RQE1.SG)March 30, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional UK£36k as ReNeuron Group plc (LON:RENE) drops to UK£17mMarch 1, 2022 | finance.yahoo.comReNeuron CEO Olav Hellebo Steps DownFebruary 11, 2022 | marketwatch.comReNeuron shares dive as it drops retinitis pigmentosa trialsJanuary 18, 2022 | lse.co.ukReNeuron to Exit Retinitis Pigmentosa Therapy Trials; Shares DiveJanuary 18, 2022 | marketwatch.comReNeuron re-appoints Randolph Corteling in senior research roleJanuary 11, 2022 | lse.co.ukReNeuron Group plc : Director DeclarationDecember 19, 2021 | markets.businessinsider.comHere's Why We're Not At All Concerned With ReNeuron Group's (LON:RENE) Cash Burn SituationOctober 26, 2021 | finance.yahoo.com Get ReNeuron Group News Delivered to You Automatically Sign up to receive the latest news and ratings for RENE and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin RENE Media Mentions By Week RENE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RENE News Sentiment▼0.000.48▲Average Medical News Sentiment RENE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RENE Articles This Week▼10▲RENE Articles Average Week Get ReNeuron Group News Delivered to You Automatically Sign up to receive the latest news and ratings for RENE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Marechale Capital News Today Bens Creek Group News Today Ashtead Group News Today Taylor Wimpey News Today Land Securities Group News Today Safestore News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:RENE) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy Buffett, Bezos & Congress Are Rushing Into This SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReNeuron Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ReNeuron Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RENE Stock Alerts